Brind.

Teva Pharmaceutical Industries Ltd. submitted an NDA for ecopipam to the FDA.

9 reports, 5 independent Updated Aug 30

Gone quiet Reached 2 outlets in its first 24 hours

Reports: 9
Developments: 2
Repetition: 78%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 5 independent outlets

Teva Pharmaceutical Industries Ltd. submitted an NDA for ecopipam to the FDA.

Who's involved

What this event is mainly about

FDA Teva Pharmaceutical Industries Ltd.

How it developed

Newest first. Tap a step to see who reported it.

Aug 30FDA accepted NDA for ecopipam treatment.1 source
- yahoo.com
Jun 1Teva submitted an NDA for ecopipam to the FDA.2 sources
- manilatimes.net
- pmlive.com

Keep exploring

The entities involved

FDA
- Clene Inc. submitted an NDA to the FDA seeking accelerated approval while trading on the Nasdaq exchange.11:34
- The FDA approved a new manufacturing process for biosimilar by Alvotech, with Joseph McClellan serving as COO.09:53
Teva Pharmaceutical Industries Ltd.
Israeli pharmaceutical company

Nothing else this week.

Related events

A company is seeking definitive data for a pre-NDA meeting with the FDA in Raleigh.Oct 6

Coverage

Newest first; wire copies grouped

3 more outlets ran the same wire story